Mar 07, 2022 / 02:10PM GMT
Yaron Werber - Cowen and Company, LLC - Analyst
Okay. Well, good morning, everybody, and thank you once again for joining us for the 42nd Annual Health Care Conference at Cowen. I'm Yaron Werber from the biotech team. And it's a great pleasure to moderate the Orphan Neurology Panel with my colleagues, Brendan Smith and Eva Privitera.
We really have a terrific session today. We have with us, Shoshana Shendelman, who is the Founder and CEO of Applied Therapeutics; Brett Monia, who's the CEO of Ionis; Jeremy Levin, who's the CEO of Ovid; and Ed Kaye from Stoke. Gentlemen and lady, thank you so much for joining us. Great to see you.
Brett Monia - Ionis Pharmaceuticals, Inc - CEO
Thank you.
Ed Kaye - Stoke Therapeutics, Inc. - CEO & Director
Thank you very much.
Questions and Answers:
Yaron Werber - Cowen and Company, LLC - AnalystSo we have a lot to talk about. There's a lot going on in orphan neuro these days and you're all essentially developing therapies
Trustpilot
